Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019
- PMID: 35066637
- DOI: 10.1007/s00345-021-03913-0
Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019
Abstract
Purpose: We aimed to estimate the burden of UTIs by age, sex, and socioeconomic status in 204 countries and territories from 1990 to 2019.
Methods: We used data from Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to analyse the incidence, mortality, and disability-adjusted life-years (DALYs) due to UTIs at the global, regional, and national levels. Estimates are presented as numbers and age-standardised or age-specific rates per 100,000 population, with 95% uncertainty intervals (UIs). We further explored the associations between the incidence, mortality, DALYs, and socio-demographic index (SDI) as a proxy for the development status of regions and countries.
Results: In 2019, more than 404.6 million (95% UI 359.4-446.5) individuals had UTIs globally and nearly 236,786 people (198,433-259,034) died of UTIs, contributing to 5.2 million (4.5-5.7) DALYs. The age-standardised incidence rate increased from 4715.0 (4174.2-5220.6) per 100,000 population in 1990 to 5229.3 (4645.3-5771.2) per 100,000 population in 2019. At the GBD regional level, the highest age-standardised incidence rate in 2019 occurred in Tropical Latin America (13,852.9 [12,135.6-15,480.3] per 100,000 population). At the national level, Ecuador had the highest age-standardised incidence rate (15,511.3 [13,685.0-17,375.6] per 100,000 population). The age-standardised death rates were highest in Barbados (19.5 [13.7-23.5] per 100,000 population). In addition, age-standardised incidence, death, and DALY rates generally increased across the SDI.
Conclusions: Our study results suggest a globally rising trend of UTI burden between 1990 and 2019.
Keywords: Burden; GBD 2019; Global; Incidence; UTIs.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Stamm WE, Norrby SR (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183(Suppl 1):S1–S4. https://doi.org/10.1086/318850 - PubMed
-
- Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007. Vital Health Stat Ser Data Natl Health Surv 169:1–38
-
- Uçkay I, Sax H, Gayet-Ageron A et al (2013) High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional study. Antimicrob Resist Infect Control 2(1):5. https://doi.org/10.1186/2047-2994-2-5 - PubMed - PMC
-
- Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Month DM 49(2):53–70. https://doi.org/10.1067/mda.2003.7
-
- Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG (2018) Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res 18(1):107–117. https://doi.org/10.1080/14737167.2017.1359543 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical